Announcements Archive

Displaying 1 - 10 of 75
Policies
12.28.2023

CIRB Stakeholders,

As of January 2, 2024, each study closure will require the completed and approved Early Study Closure Confirmation form. The Early Study Closure Confirmation form will be required for all studies, even those where no participants have been enrolled. 

Notices
10.11.2023

CIRB STAKEHOLDERS,
 

The CIRB’s Annual Signatory Institution Worksheet and Quickguide have been revised to reflect changes to the following questions:

Notices
08.01.2023

CIRB Stakeholders,

To provide a more updated and integrated experience for all stakeholders who reach out to the NCI CIRB Helpdesk, we are transitioning to a new helpdesk management system (Zendesk). 

Notices
06.22.2023

CIRB Stakeholders,

The NCI CIRB is announcing its annual ‘open call’ for new board members. Our goal is to populate the boards with members who represent diverse backgrounds and experiences, and who can review NCIs research with competence and confidence. This year we are recruiting for medical oncologists and statisticians. We will be accepting applications through July 21st. 

Notices
06.08.2023

Hello,

The NCI CIRB is announcing its annual ‘open call’ for new board members. Our goal is to populate the boards with members who represent diverse backgrounds and experiences, and who can review NCIs research with competence and confidence. This year we are recruiting for medical oncologists and statisticians. We will be accepting applications through July 21st. 

Notices
05.31.2023

Unanticipated Problem and/or Serious or Continuing Noncompliance Application

The NCI CIRB has created an application for the submission of potential unanticipated problems and/or serious or continuing noncompliance for trial-wide review by the boards. 

Policies
10.03.2022

CIRB Stakeholders,

The NCI CIRB has updated its guidance regarding the requirements for a witness.  Witnesses will no longer be required by NCI.  The inclusion of a witness in the remote consent process is now dictated by local institutional policy and must follow FDA and OHRP requirements.

Thank you

CIRB Operation Office

Notices
09.29.2022

On April 10, 2023, President Biden signed the bill officially ending the COVID-19 national emergency for the United States. All allowed COVID-19 deviations and reporting requirements are now discontiunued.

The following section will be retained for archival purposes.

 

*****************************************************************************************************

Notices
09.29.2022

On April 10, 2023, President Biden signed the bill officially ending the COVID-19 national emergency for the United States. All allowed COVID-19 deviations and reporting requirements are now discontiunued.

The following section will be retained for archival purposes.

 

*****************************************************************************************************

 

Displaying 1 - 10 of 75